Shalini Singh

Shalini Singh

Auto-generated profile, based on publicly available information

Shalini Singh

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Gynecologic Oncology
Verified
Journal Article
Closed access
SSShalini Singh
Shalini Singh
Niloy Ranjan DattaNiloy Ranjan Datta
Niloy Ranjan Datta
NKNarendra Krishnani
Narendra Krishnani
PLPunita Lal
Punita Lal
SKShaleen Kumar
Shaleen Kumar

1 August 2004 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
YNY. S. Nagar
Y. S. Nagar
SSS. Singh
S. Singh
SKS. Kumar
S. Kumar
PLP. Lal
P. Lal
Background The advantage of 4-field radiation to the pelvis is that the use of lateral portals spares a portion of the small bowel anteriorly and rectum posteriorly. The standard lateral portals defined in textbooks are not always adequate especially in advanced cancer cervix. Methods An analysis was done to determine adequacy of margins of standard lateral pelvic portals with CECT defined tumor volumes. The study included 40 patients of FIGO stage IIB and IIIB treated definitively for cancer cervix between 1998 and 2000. An inadequate margin was defined if the cervical growth and uterus were not encompassed by the 95% isodose. Results An inadequate posterior margin was common with bulky disease (P = 0.06) and with retroverted uterus (P = 0.08). Menopausal status, FIGO stage, associated myoma, and age were of no apparent prognostic significance. Bulk retained significant on multivariate analysis. An inadequate anterior margin was common in premenopausal (P = 0.01); anteverted uterus (P = 0.02); associated myoma (P = 0.01); and younger patients (P = 0.03). It was not influenced by bulk or stage. Menopausal status and associated myoma retained significant on multivariate analysis. Conclusion Without the knowledge of precise tumor volume, the 4-field technique with standard portals is potentially risky as it may under dose the tumor through lateral portals and the standard AP/ PA portals are a safer option.

1 November 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
CJChandan Kumar Jha
Chandan Kumar Jha
AMAnjali Mishra
Anjali Mishra
SYSubhash Yadav
Subhash Yadav
GAGaurav Agarwal
Gaurav Agarwal
SSShalini Singh
Shalini Singh
SMsaroj kanta mishra
saroj kanta mishra
Objective: The relationship of thyroid dysfunction and autoimmunity with breast cancer (BC) continues to be contentious.The primary aim of this study was to estimate the prevalence of thyroid dysfunctions and autoimmunity in BC patients, and the secondary aims were to investigate the relationship of thyroid dysfunction with the clinicopathological profile of and therapy received by BC patients. Materials and methods. This was a single-center prospective case-control study (March 2015-May 2017). Women with BC (n = 191), age-matched healthy controls (n = 166) and malignant controls (patients with cervical cancer, n = 87) were enrolled. Basal serum free thyroxin (fT4), thyrotropin (TSH) and anti-thyroid peroxidase (TPO) antibody levels were measured in all three groups; fT4,TSH andTPO measures were repeated after chemotherapy and at the 1-year follow-up (one year after diagnosis) in the BC patients. Results: The prevalence of overall hypothyroidism and autoimmunity (p = 0.106) did not differ significantly between the three groups, but the rate of clinical hypothyroidism was significantly higher in the BC group than in the healthy control group and the malignant control group (12.2% vs. 3.0% vs. 4.6%, respectively; p= 0.001). BC patients had significantly lower mean basal TSH concentrations than the healthy controls (p = 0.017). The postchemotherapy TSH concentrations were significantly lower (p = 0.001), and the fT4 concentrations were higher, albeit not significantly (p = 1.00), than the respective basal concentrations.The reverse was true for the follow-up values, in which the TSH (p = 1.00) values were higher and the fT4 (p = 0.03) concentrations were lower than the respective basal concentrations. An additional 6% of the BC patients developed clinical hypothyroidism during follow-up. Hypothyroid (p = 0.02) and TPO-positive (p = 0.004) patients had significantly smaller tumors, but their other clinicopathological features were comparable to those without thyroid dysfunction. Conclusions. The prevalence of clinical hypothyroidism requiring thyroxine replacement was significantly high in BC patients and increased further during follow-up. Hence, BC patients should be considered a high-risk group that should receive routine screening for hypothyroidism.

19 November 2026 in Indian Journal of Gynecologic Oncology
Verified
Journal Article
Closed access
PKParuj Khan
Paruj Khan
SSShalini Singh
Shalini Singh
AMArundhati Mohan
Arundhati Mohan
ARAnju Rani
Anju Rani
RRRam Nawal Rao
Ram Nawal Rao